BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37174090)

  • 1. CD51 Intracellular Domain Promotes Cancer Cell Neurotropism through Interacting with Transcription Factor NR4A3 in Colorectal Cancer.
    Huang T; Lin Y; Chen J; Hu J; Chen H; Zhang Y; Zhang B; He X
    Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined inhibition of surface CD51 and γ-secretase-mediated CD51 cleavage improves therapeutic efficacy in experimental metastatic hepatocellular carcinoma.
    Cai J; Wang J; Jiang C; Ye L; He X; Huang J; Sun X; Ren Z; Lai X; Qiu Y; Wang H; Lv G; Zheng J; Lu T; Chen H; Liu Y; Chen H; Guan Y; Wang Y; Wang T; Yao J; Sui X; Kang Y; Zhang Y; Li H; Wang J; Li W; Chen G; Yang Y; Xiang AP
    J Hepatol; 2023 Dec; 79(6):1418-1434. PubMed ID: 37604269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of perineural invasion in stages II and III colorectal cancer.
    Zhou Y; Wang H; Gong H; Cao M; Zhang G; Wang Y
    Pathol Res Pract; 2015 Nov; 211(11):839-44. PubMed ID: 26429129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perineural invasion is associated with poor prognosis of colorectal cancer: a retrospective cohort study.
    Cao Y; Deng S; Yan L; Gu J; Li J; Wu K; Cai K
    Int J Colorectal Dis; 2020 Jun; 35(6):1067-1075. PubMed ID: 32179991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100-stained perineural invasion is associated with worse prognosis in stage I/II colorectal cancer: Its possible association with immunosuppression in the tumor.
    Fukuda Y; Tanaka Y; Eto K; Ukai N; Sonobe S; Takahashi H; Ikegami M; Shimoda M
    Pathol Int; 2022 Feb; 72(2):117-127. PubMed ID: 35007380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of perineural invasion in patients with colorectal cancer.
    Hu G; Li L; Hu K
    Medicine (Baltimore); 2020 Apr; 99(17):e19860. PubMed ID: 32332645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perineural Invasion is a Strong Prognostic Factor in Colorectal Cancer: A Systematic Review.
    Knijn N; Mogk SC; Teerenstra S; Simmer F; Nagtegaal ID
    Am J Surg Pathol; 2016 Jan; 40(1):103-12. PubMed ID: 26426380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perineural invasion is a prognostic factor in stage II colorectal cancer but not a treatment indicator for traditional chemotherapy: a retrospective cohort study.
    Li J; Mei S; Zhou S; Zhao F; Liu Q
    J Gastrointest Oncol; 2022 Apr; 13(2):710-721. PubMed ID: 35557585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perineural invasion is an independent predictor of outcome in colorectal cancer.
    Liebig C; Ayala G; Wilks J; Verstovsek G; Liu H; Agarwal N; Berger DH; Albo D
    J Clin Oncol; 2009 Nov; 27(31):5131-7. PubMed ID: 19738119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of perineural invasion in patients with stage II colorectal cancer.
    Huh JW; Kim HR; Kim YJ
    Ann Surg Oncol; 2010 Aug; 17(8):2066-72. PubMed ID: 20182809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Extracellular Vesicle Stratifin Is a Biomarker of Perineural Invasion in Patients With Colorectal Cancer and Predicts Worse Prognosis.
    Hou W; Pan M; Xiao Y; Ge W
    Front Oncol; 2022; 12():912584. PubMed ID: 35936690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Genomic Alterations of Perineural Invasion in Patients with Stage II Colorectal Cancer.
    Su H; Chang C; Hao J; Xu X; Bao M; Luo S; Zhao C; Liu Q; Wang X; Zhou Z; Zhou H
    Onco Targets Ther; 2020; 13():11571-11582. PubMed ID: 33204110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphovascular or perineural invasion is associated with lymph node metastasis and survival outcomes in patients with gastric cancer.
    Zhang F; Chen H; Luo D; Xiong Z; Li X; Yin S; Jin L; Chen S; Peng J; Lian L
    Cancer Med; 2023 Apr; 12(8):9401-9408. PubMed ID: 36952439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy for the perineural invasion of colorectal cancer.
    Suzuki T; Suwa K; Ogawa M; Eto K; Kawahara H; Fujita T; Ikegami M; Yanaga K
    J Surg Res; 2015 Nov; 199(1):84-9. PubMed ID: 25935467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphovascular and perineural invasion are associated with poor prognostic features and outcomes in colorectal cancer: A retrospective cohort study.
    Al-Sukhni E; Attwood K; Gabriel EM; LeVea CM; Kanehira K; Nurkin SJ
    Int J Surg; 2017 Jan; 37():42-49. PubMed ID: 27600906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional imaging of intramural perineural invasion in colorectal cancer: Three-dimensional reconstruction approach with multiple immunohistochemically stained sections.
    Miyashita Y; Ikeda T; Shinto E; Okano S; Korehisa S; Shimazaki H; Oki E; Ueno H; Oda Y; Mori M
    Pathol Int; 2022 May; 72(5):293-299. PubMed ID: 35352858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of tumour deposit and perineural invasion status in colorectal cancer patients: a SEER-based population study.
    Mayo E; Llanos AA; Yi X; Duan SZ; Zhang L
    Histopathology; 2016 Aug; 69(2):230-8. PubMed ID: 26802566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100 Staining Adds to the Prognostic Significance of the Combination of Perineural Invasion and Lymphovascular Invasion in Colorectal Cancer.
    Conte GA; Qari O; Fasano GA; Guinto RK; Palo L; Parker GS; Rangwala AF; Minassian H; Greenberg PJ; Dewan AA; Topilow AA
    Appl Immunohistochem Mol Morphol; 2020; 28(5):354-359. PubMed ID: 30585786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of
    Ma J; Guo D; Miao W; Wang Y; Yan L; Wu F; Zhang C; Zhang R; Zuo P; Yang G; Wang Z
    Abdom Radiol (NY); 2022 Apr; 47(4):1244-1254. PubMed ID: 35218381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asparagine Synthetase-Mediated l-Asparagine Metabolism Disorder Promotes the Perineural Invasion of Oral Squamous Cell Carcinoma.
    Fu Y; Ding L; Yang X; Ding Z; Huang X; Zhang L; Chen S; Hu Q; Ni Y
    Front Oncol; 2021; 11():637226. PubMed ID: 33777794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.